In the Clinical/Scientific Note “A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS” by Rolfes et al.,1 first published online November 8, 2019, the label in figure 1F should read “Abdominal CT scan outlining extensive abdominal (yellow arrows) and inguinal (red arrows) lymphadenopathy.” The authors regret the error.
- © 2019 American Academy of Neurology
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab
Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy
Antibody-positive paraneoplastic neurologic syndromes